Pet Diabetes Care Market SizeTo Reach $4.6 Billion By 2033

Pet Diabetes Care Market Growth & Trends

The global pet diabetes care market size is expected to reach USD 4.6 billion by 2033, expanding at a CAGR of 9.4% from 2026 to 2033, according to a new report by Grand View Research, Inc. The growing number of companion animals, the high rate of pet adoption, increased spending on pets, and the rising incidence of diabetes mellitus in dogs and cats are the key factors driving the market's growth.

With a significant rise in the prevalence of diabetes mellitus in companion animals, several key players are making investments in R&D to support innovations and advancements in diabetes care devices as well as treatment to introduce novel products in the market. For instance, The ALRT Animal Health Division, a new business division established by ALR Technologies SG Pte Ltd., launched a continuous glucose monitor for diabetic pet animals in June 2021.

The COVID-19 pandemic had a notable impact on the pet diabetes care industry. This included operational challenges, supply chain hurdles, and restricted access to veterinary care. The market thus faced lowered demand in 2020. However, governments and veterinary organizations of various countries implemented strategies and safety measures to resume veterinary practices during the pandemic.

According to the American Veterinary Medical Association, telemedicine services were widely incorporated in veterinary clinics and hospitals to curb the impact of lockdowns and the pet parents were given digital training to inject insulin. The pandemic also led to a surge in pet adoption, increased pet humanization owing to a stronger pet-parent bond, and increased pet expenditure. This is expected to drive market growth in the coming years.

The increased pet care expenditure in both developing and developed economies is a significant opportunity considered for market growth. According to the American Kennel Club (AKC), pet owners in the U.S. were seen to spend more money on their pet’s wellness and related healthcare products. The American Pet Products Association reported that the total value of pet industry sales exceeded USD 120 billion by 2021 end. The AKC also stated that online veterinary product shopping increased by 86% after the emergence of the pandemic. The trend of owning popular breeds of dogs and cats also enhanced the required routine veterinary and diabetic care services among them. These factors are expected to boost the growth of the market.

The increasing pet humanization all over the world as well as the large population of pet owners who are concerned about the general health of the pet and frequently pursue veterinary care are contributing to favorable growth in the market. Additionally, the extensive use of insulin therapy for diabetic canines and felines, which lowers blood sugar levels by raising peripheral glucose uptake and suppressing hepatic glucose production, is encouraging market expansion. Also, the development of smart wearables to AI technologies and machine learning (ML), as well as the internet of things (IoT) for monitoring pets' health remotely is proving to be a driving force in the market's expansion.

 Request a free sample copy or view report summary: Pet Diabetes Care Market Report

Pet Diabetes Care Market Report Highlights

• The dog segment dominated the market by animal type in 2025. The segment is primarily driven by a rise in dog ownership around the world.

• The treatment segment held the largest market share in 2025. Since insulin therapy helps move glucose from food into other areas of the body, veterinarians view it as the gold standard for treating diabetes in companion.

• The veterinary hospitals & clinics segment accounted for the largest revenue share of 40.0% in 2025. This is due to their central role in the diagnosis, treatment, and long-term management of diabetes in companion animals.

• The North America pet diabetes care market held the largest share of 37.2% in 2025. The market is driven by the region's well-established veterinary healthcare infrastructure and high adoption of advanced diabetes management technologies.

Pet Diabetes Care Market Segmentation

Grand View Research has segmented the global pet diabetes care market report based on solution, animal, distribution channel, and region:

Pet Diabetes Care Solution Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• Treatment

  • Insulin Therapy

  • Insulin Delivery Devices

• Other Treatments

• Glucose Monitoring Devices

Pet Diabetes Care Animal Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• Dogs

• Cats

• Others

Pet Diabetes Care Distribution Channel Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• Veterinary Hospitals & Clinics

• Retail Pharmacies

• E-commerce

Pet Diabetes Care Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Norway

  • Sweden

  • Denmark

• Asia Pacific

  • Japan

  • India

  • China

  • South Korea

  • Thailand

  • Australia

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

  • Oman

  • Qatar

List of Key Players of Pet Diabetes Care Market

• Merck & Co., Inc.

• Zoetis

• BD

• Boehringer Ingelheim International GmbH

• Nova Biomedical

• Allison Medical, Inc.

• AccuBioTech Co., Ltd

• i-SENS, Inc.

• TaiDoc Technology Corporation